EGFR and neoplasm: Unlike other tumor types such as non-small cell lung cancers (NSCLCs) or melanomas, in which target mutations are associated with massive regressions following treatment with specific inhibitors [13, 14], genetic alterations of EGFR are extremely infrequent in colorectal tumors.